Log in to save to my catalogue

World Heart Federation consensus on transthyretin amyloidosis cardiomyopathy (ATTR-CM)

World Heart Federation consensus on transthyretin amyloidosis cardiomyopathy (ATTR-CM)

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a1f0ff282fae4f62a6cb5dd78cdd1f0c

World Heart Federation consensus on transthyretin amyloidosis cardiomyopathy (ATTR-CM)

About this item

Full title

World Heart Federation consensus on transthyretin amyloidosis cardiomyopathy (ATTR-CM)

Publisher

England: Ubiquity Press

Journal title

Global Heart, 2023-01, Vol.18 (1), p.59-59

Language

English

Formats

Publication information

Publisher

England: Ubiquity Press

More information

Scope and Contents

Contents

COPYRIGHT: © 2023 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See http://creativecommons.org/ licenses/by/4.0/.
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and fatal condition that requires early diagnosis, management, and specific treatment. The availability of new disease-modifying therapies has made successful treatment a reality. Transthyretin amyloid cardiomyopathy can be either age-related (wild-type form)...

Alternative Titles

Full title

World Heart Federation consensus on transthyretin amyloidosis cardiomyopathy (ATTR-CM)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a1f0ff282fae4f62a6cb5dd78cdd1f0c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a1f0ff282fae4f62a6cb5dd78cdd1f0c

Other Identifiers

ISSN

2211-8179,2211-8160

E-ISSN

2211-8179

DOI

10.5334/gh.1262

How to access this item